Clinical trial
RISK Stratification Using a Combination of Cardiac Troponin T and Brain…
NCT00453622 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00453622 |
|---|---|
| Title | RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-D |
| Official title | RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-D |
| Acronym | RISK |
| Lead sponsor | Abbott Medical Devices, Industry |
| Collaborators | VA Pittsburgh Healthcare System U.S. Fed |
| Status | Completed |
| Study type | Observational |
| Conditions | Heart Failure |
| Intervention type | Device |
| Interventions | Cardiac Resynchronization Therapy-Defibrillator |
| Enrollment | 222 |
| Start date | Nov 1, 2005 |
| Primary completion | Aug 1, 2012 |
| Completion | Aug 1, 2012 |
| First posted | Mar 29, 2007 |
| Last update posted | Feb 4, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: